# FDA Approves ANDA for AUROLIFE PHARMA LLC AUROLIFE PHARMA LLC has received FDA approval for ANDA 202580, expanding its generic drug portfolio and positioning the company to capture additional market share in the competitive generic pharmaceutical sector. The approval strengthens AUROLIFE's ability to offer cost-effective therapeutic alternatives to healthcare providers and patients.